Abstract. Bronchial diseases alter the color and structural characteristics of the pulmonary mucosa through changes in blood flow, epithelial thickening, and abnormal cell growth. Current analysis of these subtle changes includes visual interpretation of the airway color and topography through bronchoscopy procedures, and quantitative multidetector-x-ray-computed-tomography ͑MDCT͒-based structural analysis, each affording valuable insights to the health of the lungs. The fusion of the bronchoscopy and MDCT image data promises to provide a synergistic data set exhibiting both mucosal color and topography crucial to fostering an understanding of airway structure and function. A real-time airway color analysis imaging system is developed and utilized to perform pulmonary mucosal color assessment in healthy volunteers with subsequent comparative studies performed in example disease states. Our results indicate that macro-optical digital bronchoscopes with appropriate image analysis may have a significant impact on understanding bronchial diseases. To ensure the correct interpretation of scene content, which is critical in the assessment of airway topography, we are developing methods of extracting 3-D structure from 2-D bronchoscope images utilizing MDCT imaging techniques. The resulting 3-D true-color images of the pulmonary mucosa facilitate the combination of mucosal color and topography analysis as well as region of interest localization within the airway tree.
Introduction
Alterations to the airway mucosa as a result of the development of lung carcinomas and chronic obstructive pulmonary disease ͑COPD͒ include both observable structural and color changes possibly due to the disturbances in the blood supply, epithelial thickening, altered cell type, and associated genetic and molecular changes in the airway mucosa. Genetic and molecular changes remain poorly understood as a consequence of limited techniques in associating them with the structural and functional changes. The ultimate goal in imaging the pulmonary airways is to provide a diagnostic and evaluation tool such that both potential structural and function alterations can be identified in the hope of assisting patient treatment and care provided by the physician.
Bronchoscopy
The initial step in the identification of pulmonary airway disease is typically a bronchoscopy procedure, 1 which may be performed as a result of a persistent or unexplained cough, the presence of blood in the sputum, an abnormal chest x-ray, or the evaluation of a possible lung infection. A bronchoscope is a long, flexible visualization instrument that is inserted into either the nose or the mouth to gain access to the airways. The physician is able to make an initial visual evaluation based on this inspection. Although the qualitative analysis of the mucosal topography and color is possible through bronchoscopic exploration, many of the bronchoscopes currently used in pulmonary diagnostic centers are monochromatic, CCD chip bronchoscopes. The images from these bronchoscopes are presented in color to the physician, however, this observed color is added falsely through illumination effects. The light source used in conjunction with such bronchoscopes repeatedly flashes red, green, and blue, causing the light to appear to the human observer as white light. To construct the color images, the responses of the CCD chip to each of the three light stimuli are combined to form the red, green, and blue components of a 24-bit true-color image. The observed airway epithelial color is therefore greatly susceptible to interscope and interillumination disparities as well as the obvious interobserver variability due to the inherently subjective nature of visual color interpretation. Research into the color changes accompanying the development of lung disease to date has been minimal due to the limitations of appropriate imaging devices. Developments in bronchoscope technology 2, 3 have resulted in bronchoscopes with trichromatic, CCD chips. As a result it is now feasible to perform digital color analysis of the pulmonary airway mucosa in an attempt to facilitate a greater understanding of pulmonary airway disease response.
The assessment of the pulmonary airways through traditional bronchoscopy is relatively noninvasive, and provides a visual link to the mucosal topography and color, however, alone is generally not sufficient for accurate disease diagnosis. The subtle changes that indicate early changes in disease development may often be missed as a result of this highly subjective assessment especially in inexperienced bronchoscopists. A bronchoscope is also restricted to the upper airway generations and thus this form of assessment alone may miss changes occurring in the lower generation bronchi.
Biopsy
A bronchial airway forceps biopsy is traditionally performed in conjunction with a bronchoscopy procedure to evaluate the airway mucosa further. The biopsy affords epithelium and basement membrane tissue specimens for histopathological analysis, including in some cases special staining for molecular and genetic changes. The diagnostic and investigational efficacy of tissue biopsy techniques is limited due to the invasive nature of the technique and the relatively small sample region size attainable. This is especially problematic if the disease process has significant heterogeneity. An additional limitation of airway forceps biopsy is the identification of a region of interest of which to biopsy. Many pulmonary airway diseases are localized and/or show very little visual differentiation between the healthy mucosa, thus identification through a bronchoscopist's visual interpretation may lead to abnormal mucosa being overlooked.
Multidetector X-Ray-Computed Tomography

͑MDCT͒-Based Imaging Techniques
A further technique for disease detection and classification in the airways is through external imaging modalities, particularly MDCT imaging. High-resolution MDCT imaging can provide both structural and functional information to the characterization of the lung parenchyma, 4, 5 and increasingly these image data sets are being evaluated for other structural features. The structural analysis associated with the 3-D volumetric data sets obtained from MDCT imaging techniques is widely known and facilitates quantitative anatomical airway feature analysis, including airway tree diameter, surface topography, and wall thickening. 6 Presently research in functional MDCT imaging, which is often not recognized as an aspect of MDCT imaging, includes regional ventilation and perfusion studies, regional pulmonary vascular transport characteristics, and regional pulmonary ventilation studies. 4, 5 MDCT benefits further extend to airway stenting procedures, including stent sizing, longitudinal examination of individual subjects, and surgical planning. Although the use of volumetric MDCT imaging in the detection and diagnosis of respiratory disease has clear advantages, including that the analysis is not limited to regions accessible with a traditional bronchoscope, and the valuable 3-D structural measurements, shortcomings still exist. For instance, the radiation dose associated with MDCT can be potentially harmful to the patient, and that MDCT images lack important information regarding airway mucosal color attainable with bronchoscopy procedures.
Multimodality Image Fusion
Given the prevalence and, in diseases such as cancer and cystic fibrosis, the high mortality rate of respiratory disease and in particular pulmonary airway disease it is apparent that further advancements in methods for screening, detecting, diagnosing, and tracking are required. Currently diagnosis and detection of the state of a patient's airways is generally initiated via visualization of the pulmonary airways either by macrooptical techniques such as bronchoscopy, or by external imaging techniques such as MDCT. Both techniques provide valuable information to the health of the airway mucosa such as mucosal color that may be an indicator of airway inflammation, or airway tree structure that may indicate regions of stenosis where the airway branch closes in on itself; however, each technique also has associated limitations. To enhance the abilities of these imaging techniques to aid in the determination of airway structure and function it is proposed that the image information be adapted and fused to provide a synergistic and coherent dataset.
The use of multimodality imaging in the medical field has grown considerably in recent years due in part to the advancement in various imaging techniques required to visualize anatomical and physiological structure and function. A familiar quandary faced in multimodality imaging is the fusion of the two varying imaging techniques to obtain a synergistic data set utilizing all available information. This multimodality image-based registration may be generally straightforward when the conflicting modalities have similar image structure, however, the registration complexity is significantly increased when the opposing imaging modality structure is nonuniform. The evaluation of the pulmonary airways involves both traditional clinical bronchoscopy techniques and more modern approaches involving 3-D volumetric MDCT techniques such as virtual bronchoscopy. We propose to merge these complimentary imaging modalities through a unique technique utilizing both shape from shading and virtual bronchoscopy imaging techniques.
Methods
As previously stated, the aim of this research is to analyze and merge pulmonary mucosal structure and color information for use in furthering our understanding of abnormalities occurring as a result of pulmonary airway disease. An initial multifaceted solution to this goal was obtained including the requisite image acquisition steps ͑macro-optical and MDCT͒ followed by a series of complex post acquisition image processing procedures. A flow diagram depicting the major components to this solution is shown in Fig. 1 . A macro-optical imaging system was devised to collect digital 2-D color images of the pulmonary airways. These images were consequently analyzed for mucosal color anomalies that were highlighted on the original 2-D image. Following the 2-D mucosal color analyses was the process of merging the airway structure and color. First, the bronchoscope images were corrected for lens distortion effects to obtain perspective projection images. Rigid mutual information image registration was used to register both the distortion corrected macro-optical bronchoscope images together with the corresponding virtual bronchoscopy image. The virtual bronchoscopy was created through segmentation of the airway lumen from the MDCT image data followed but surface rendering and defining the virtual cameras 3-D position. An initial estimate of the virtual bronchoscope view is performed manually followed by the automated image registration. The purpose of performing this registration is to extract initialization parameters for the consequent shape from shading ͑SFS͒ analysis used to determine the final 3-D structure. Each of these major processing steps are further detailed in the following.
Macro-Optical Image Acquisition
In 2001 the Olympus Corporation released the 160 series digital bronchoscopes comprising of distal trichromatic CCD chips. Previously digital bronchoscopes consisted of grayscale CCD chips, and thus the appearance of color was through a false coloring process. The coloring process is reliant on the use of a rapidly rotating color wheel. The color wheel consists of red, green, and blue ͑RGB͒ filters. During a single rotation of the color wheel, three images are captured corresponding to white light illumination being transmitted through each of the filters. The three image signals detected are then combined to form a single-color RGB image. Although this coloring technique does result in realistic pseudocolor images, the images are not an accurate representation of the true color of the airway mucosal surface.
To take advantage of the color detection capabilities of the new color digital bronchoscopes, we developed an airway mucosal color imaging system that will facilitate quantitative analysis of the airway epithelium. Physicians for many years have qualitatively assessed airway mucosal color changes in the digital pseudocolor bronchoscope images, however, due to the subjective nature of this assessment, inter-and intraobserver variation has not been quantitatively assessed. The trichromatic bronchoscope used in the imaging system is connected to an Olympus EVIS Video System Tower. The tower consists of an illumination source, a video processor, a monitor, and video recording and printing facilities. In standard bronchoscope practice, an illumination source is required to visualize the airways. The detection of color is heavily dependent on the illumination source and thus the quality of a source is often described by a color-rendering index, which refers to the quality of the illumination, and hence the ability of the source not to distort the appearance of measured colors. The Olympus EVIS Universal Light Source ͑CLV-U40͒ used in this system has a high quality xenon 300-W short arc lamp with a superior color-rendering index. The intensity of the xenon lamp is controlled by an automatic gain control. The automatic brightness control on the illumination source ensures that sufficient light is available to visualize the airways while preventing adverse effects of overillumination, such as CCD blooming effects, when the storage capacity of the CCD wells are exceeded, and eye damage or exposed tissue burns.
The digital color images captured by the color CCD chip bronchoscope are transferred to the video processor unit, where, among other processing steps, they are converted to an analog signal and displayed on a color monitor for immediate visualization by the medical team. The current Olympus digital video processor systems do not allow for the direct transferal of the digital feed from the bronchoscope and thus in order to re-digitize this real time image information a Matrox Meteor II frame grabber is employed. The frame grabber, essentially an image acquisition peripheral component interconnection ͑PCI͒ card, is installed on a PC and is connected to the video output channels of the bronchoscope monitor via a DBH44 to 8BNC cable. The 640ϫ 480 8-bit digital images of the monitor output are captured at a rate of 30 frames/s and are consequently stored and displayed on the PC for either concurrent or future color analysis.
Mucosal Color Analysis
Many color-encoding methods exist including hue, saturation, intensity ͑HSI͒, YIQ ͑used in television broadcasting͒, XYZ ͑used by the CIE Chromaticity diagram͒, and the popular RGB system. Although color is commonly represented in the RGB color space, the HSI color space was selected for use in our color analysis system. The HSI color space is relatively insensitive to changes in the illumination intensity, assuming that the illumination source is "pure." An increase or decrease in the illumination intensity results only in a corresponding increase or decrease in the I parameter rather than changing each of the three color components as is the case in the RGB color encoding system. The HSI color space mirrors the perception of color by the human eye thus supporting a clear understanding of the measured values. 7 Hue is a measure commonly referred to as color ranging from red through yellow, green, and blue and is determined by the dominant light wavelength or photon frequency. Saturation is a measure of the purity of a particular hue, or alternatively a measure of the degree of white light present. The images captured with a bronchoscope are not exposed to uniform scene illumination as tissue regions at a great distance from the bronchoscope tip and hence the light source receive lower intensity illumination than those within close proximity of the bronchoscope tip. Due to the reliance of the I parameter on the scene illumination, it was not considered in our color analysis. H and S values are commonly represented on a color wheel. Hue is measured in degrees ranging from 0 to 360 with 0, 120, and 240 deg corresponding to red, green, and blue, respectively, with intermediate values linearly spaced between. Saturation is measured as a percentage, with 100% saturation depicted on the radius of the color wheel and all other intermediates linearly scaled along the wheel radius.
The use of color analysis has been used for a number of years in dermatology, specifically in the assessment of skin lesions. These color analysis techniques often involve color calibration techniques to ensure that the measured color is independent of the imaging system. Color images from a detection system are dependent on three parameters: the physical content of the scene, the illumination incident on the scene, and the characteristics of the camera. The aim of color constancy is to account, if necessary, for the effects of illumination either by mapping the image to an illuminant invariant representation or by determining the description of the illumination for color correction. Integrated into the Olympus Video System Tower is a white balance control. This white balance is a form of color constancy where each of the trichromatic RGB channels is scaled by their maximum value in the image when the scene contains a pure white color patch. Olympus provides a pure white bronchoscope cap with the bronchoscope system that encapsulates the distal tip of the bronchoscope. With this cap is in place, the white balancing calibration process is performed prior to using the system. Software to control the image acquisition ͑by the video frame grabber͒, display, storage, and analysis was developed in Microsoft Visual Studio software development package. The customized software supports various modes of operation including the capture of healthy patient, the capture of potentially diseased patient, the analysis of stored, as well as the real-time capture and analysis of airway images. During the collection of healthy patient data, either single images or image sequences are acquired and stored for potential future use. Prior to the images being saved to disk, H and S values for each pixel in the image are determined via the following set of equations, and are consequently added to a cumulative database of healthy patient color information.
Analysis of captured airway images, weather this is in real time or post acquisition, involves the comparison of individual image pixel H and S values to those stored in the cumulative normative database. Should the pixel color values fall outside two standard deviations of those deemed to be healthy, the individual pixel values and hence region of interest are highlighted on the original color bronchoscope image.
Bronchoscope Image Distortion Correction
Generally, endoscopes used in current clinical practice are designed to include fish-eye lenses that induce barrel distortion in the resulting image output. The reason for the inclusion of these lenses is to increase the field of view of the bronchoscope, providing the physician with a greater view of the surrounding environment, however, as a result the interpretation of the image scene is compromised. To facilitate the fusion of both the MDCT-generated image data and the macro-optical images collected with the color bronchoscope, correction of this barrel distortion is required. Many algorithms exist for lens distortion correction. One such algorithm was introduced by Asari et al. 8 in 1999, and was further improved by Helferty et al. 9 in 2001. Helferty's algorithm requires the used of a calibration grid consisting of a rectangular lattice of equally spaced dots. An image of the grid is captured by the endoscope and correction parameters are calculated through an iterative optimization calculation. The desired correction parameters are those that are able to successfully map the grid rows and columns into straight lines with zero curvature. The correction coefficients are calculated in the horizontal and vertical directions independently via the following equation for the x axis. a n x ͑⌬ + 1͒ = a n
where a 1 x , ... ,a N x are the correction coefficients, ␣ specifies the convergence rate, ␤ is the expansion index, E x is the horizontal row error, ‫ץ‬E / ‫␣ץ‬ n x is the error gradient, and ⌬ specifies the iteration number. At each iteration, the error is determined by summing the distances from each dot to the corresponding grid-line fit, which is a measure how closely the new dot positions represent parallel lines. The correction coefficients for the y axis are computed by the same approach. The final image distortion correction coefficients are determined by combining the individual horizontal and vertical components. a n = a n x + a n y 2 , n = 1, . . . ,N
The goal of the distortion correction algorithm is to map the rows and columns of the captured grid into straight lines. Unlike many of the alternative algorithms, this method does not assume that the rows and columns are perfectly horizontally and vertically aligned, but rather assumes that the lines are parallel to one another with the same slope. As a consequence of this assumption, there is some degree flexibility in the alignment of the calibration grid with respect to the endoscope lens. To ensure that the endoscope is held perpendicular to the calibration grid a customized endoscope stand, identical to that used by Helferty et al. 9 , was utilized. The calculation of the distortion correction parameters are required to be computed only once for each endoscope and can consequently be applied to all images collected by that individual bronchoscope to correct for the barrel distortion. The resulting calculated correction parameters are then applied to each pixel in the distorted image to map to the corrected space via the following equation, where represents the Euclidean distance from the distortion center to a pixel in the corrected space, and Ј represents the Euclidean distance from the distortion center to the same pixel in the barrel distorted space:
Following the determination of the correction parameters for the individual bronchoscope, a look-up table is constructed providing pixel locations in the distorted image corresponding to each pixel value in the corrected image. To do this we require the inverse polynomial coefficients a 1 Ј x , ... ,a N Ј x , such that
The pixel values for the look-up table are then determined as
where ͑u x , u y ͒ is the image distortion center, = ͓͑x − u x ͒ 2 + ͑y − u y ͒ 2 ͔ 1/2 , and the inverse polynomial coefficients are solved using least squares. The full details of this method can be found in Helferty et al. 
Virtual Bronchoscopy
The development and clinical use of virtual bronchoscopy software has increased in recent years due in part to the advancements in MDCT scanners. A virtual bronchoscopy is a computer-generated visualization of a traditional bronchoscopy procedure and provides a simulated view of traversing the pulmonary airways. 10 The structure of the pulmonary airways is extracted from MDCT volumetric data through automated airway tree segmentation. The segmentation involves a combination of adaptive region growing and a hybrid method utilizing both region growing and mathematical morphology. 11 The segmented airway is then surface rendered producing a 3-D structurally accurate image of the inner pulmonary airway wall. The virtual bronchoscopy endoluminal view is generated through rapid rendering techniques where only the airway branches within the field of view are rendered. 12, 13 Once the virtual bronchoscopy views have been generated, we are able to match these views with the barrel distortion corrected images captured with the true color bronchoscope imaging system. An initial guess at the match of the virtual and true bronchoscope images is approximated at an easy to locate region of the airways such as the trachea, which is further refined through automated mutual information rigid image registration. The virtual bronchoscopy view is rotated and translated in the x, y, and z directions and the orientation that returns the maximum measure of mutual information between the two images is chosen as the correct match. Once this match is made, the depth information for each pixel in the macro-optical color bronchoscope image can be determined from the z coordinate of the corresponding pixel location within the virtual bronchoscopy view. The virtual bronchoscopy program includes a tracking algorithm to perform this image registration for consequent macro-optical images and thus update virtual bronchoscope view 14 and determine the bronchoscope location within the airway tree. At this stage of development, we are limiting our structure and color fusion to single macro-optical images.
Limitations are associated with the registration of the macro-optical color and virtual bronchoscope views, which affect the accuracy of the correct structure and color alignment. First, the lung is not a rigid structure and thus there is no way to ensure that the airways are in precisely the same 3-D shape during both the MDCT scanning and macro-optical bronchoscopy, possibly due to such factors as differences in lung volume, patient orientation, movement, or coughing. There may also be inaccuracies in the registration process itself. For these reasons the fusion of the structure and color information is not performed through direct mapping following registration but rather an initialization parameter, which does not grossly affect the resulting SFS 3-D structure, is used. This method also ensures exact alignment of the determined mucosal structure and color which is essential in future analysis of localized mucosal changes occurring during the course of an airway diseases.
3-D Shape Extraction from 2-D Bronchoscope Images
An alternative to the use of external imaging modalities, such as MDCT, in the production of 3-D bronchial trees is the inference of 3-D structural information from shading present in the 2-D bronchoscope images. Video bronchoscopes, such as the color CCD chip bronchoscope previously mentioned, provide an extremely rich and often superfluous supply of information with a single point being imaged a number of times from a number of positions. Through the exploitation of this information redundancy the development of topographical maps with a higher degree of accuracy than that available from current MDCT imaging techniques is attainable. The where E is the image irradiance, or image brightness, and is specified in the x and y image coordinates; R is the reflectance map, which models the reflected radiance and surface orientation; and the coordinates p and q represent the surface gradients.
The goal of SFS techniques is to solve the image irradiance equation and in doing so recover depth information for each pixel in the original image. There are various approaches for the determining a solution to the SFS problem including global minimization, curve propagation, and local algorithms. In traditional SFS techniques, assumptions are made regarding the scene illumination, specifically that the scene is under uniform illumination from a distant light source, that the image projection model is orthographic ͑see Fig. 2͒ and that the object surface is Lambertian. These assumptions, however, are all clearly violated in the case in bronchoscope images. The illumination source is adjacent to the camera lens on the distal end of the bronchoscope and thus tissue regions close to the bronchoscope tip will experience greater illumination than tissue regions farther down the airway lumen. Due to this close proximity of the bronchoscope tip to the airway lumen, the assumption of orthographic projection is not feasible. Orthographic projection assumes parallel projection of the scene to the image plane, essentially setting the projection center at infinity. A Lambertian surface is a surface of perfectly matte properties that reflects light radiance proportional to the cosine of the angle between the object surface normal and the illumination direction. Bronchoscope images often suffer from regions of specular reflection where the incident or illuminant source is perfectly reflected off of the object surface and hence in bronchoscope images appears as a white spot.
Okatani and Deguchi 16, 17 and Deguchi and Okatani 18, 19 first introduced an SFS technique applicable to endoscope images in 1996 by assuming a point light source at the projection center of the endoscope image rather than the uniform scene illumination previously presumed. Although this advancement did broaden the applications for SFS techniques, confining limitations still persist in the application to pulmonary airway images, including the uncertainty of the image location within the bronchial tree, and the limited observable and hence reproducible bronchial scene. To address these limitations we propose to incorporate information garnered from MDCT imaging techniques. The Okatani and Deguchi SFS algorithm for endoscope images is based on the Kimmel and Bruckstein 20 approach, where perspective projection and a point light source at the projection center are assumed. The endoscope image formation process is model through the following equation:
where represents the surface albedo, r is the distance from the surface point to the projection center, r͑x , y͒ = ͑x 2 + y 2 + z 2 ͒ 1/2 , and G͑cos ͒ is a function introduced to adjust the reflectance map for a non-Lambertian object surface. The Okatani and Deguchi developed algorithm based on the level set approach requires an initial known depth contour, ͑x , y ,0͒ =0 that is propagated via a time-based differential equation where time is proportional to depth.
At each time interval t, the curve is represented by ͑x , y , t͒ =0. This endoscope-specific SFS algorithm formed the foundation for our 3-D scene reconstruction, where f is the focal length. This Okatani and Deguchi method of SFS from endoscope images does not address the affects of the barrel distortion created by the bronchoscope fish-eye lens, and thus the resulting 3-D images will exhibit spatial inaccuracies. We address this problem through application of the distortion correction algorithm outlined in Sec. 2.3. An additional problem encountered when attempting to implement the endoscope SFS algorithm is the determination of initial conditions, particularly the initial known depth contour and location within the airway tree. Through registration of the color bronchoscope image and the corresponding virtual bronchoscope image we are able to extract this information from the virtual environment.
Experimental Methods
Eighteen healthy volunteers were recruited for a bronchoscopy procedure, at which time a series of true-color broncho- scope images were collected of the pulmonary airway mucosa. During collection of the airway images, the H and S values of each pixel in each image were determined and stored in a cumulative normative database for future use as a healthy standard to which potentially abnormal mucosal colors can be compared. Nineteen patients with known airway mucosal abnormalities were also recruited, four with excessive granulation tissue, four with papillomatosis, five with non-small-cell carcinomas, and six with idiopathic subglottic stenosis ͑see Fig. 3͒ . Likewise each of the patients with known airway abnormalities underwent a bronchoscopy procedure, however, unlike the images collected from the healthy volunteers, the potentially abnormal airway mucosal images were statistically compared to the cumulative normative database and detected abnormal colors were consequently highlighted. MDCT scans were also collected for the 19 patients with apparent pulmonary airway diseases for use in the construction of the 3-D color pulmonary images.
Results
Mucosal Color Analysis
Significant correlation was found in the intervolunteer mucosal H and S values from the eighteen healthy volunteers. A bar graph ͑see Airway mucosal colors collected from the abnormal mucosal population of patients with known pulmonary airway diseases were collated within their respective disease classes and the corresponding mean H and S values were presented in an H versus S scatterplot along with those from the healthy database, and are depicted in Fig. 6 . The scatterplot shows that in most cases the abnormal images have a clear shift in the mean H and S values from that in the normal healthy population that may not always be readily visible to the human eye. From a visual inspection of the subglottic stenosis bronchoscope images, we observe two forms of mucosal response; some of the images appear highly vascular while others appear to have significant reduced vascularity. Based on this visual observation, the two groups were divided and treated as separate classes with consequent analyses confirming this distinction. To view the contribution of the H and S values independently as a means of distinguishing between the individual disease classes, a bar graph of the respective H and S values was constructed with associated standard error bars ͑see Fig. 7͒ . Standard two-sided t tests were calculated for each of the mean H and S values in each pulmonary airway disease class against the mean H and S values in the normative database to further quantify the interdisease mucosal color variation. The results ͑Table 1͒ indicate that the difference in mean mucosal H and S values between the papillomatosis, granulation, and carcinoma disease classes and the healthy normal class are statistically significant, however, the p values determined for the two subglottic stenoses classes were not so impressive. In future classification of these pulmonary images based on mucosal color analysis, more sophisticated methods such as the use of neural networks 21 may be required where extracted features may include additional color and texture analysis.
Airway mucosal color analysis involved the comparison of the potentially abnormal airway mucosa to that of the developed healthy database. During this comparison, the H and S values for each pixel in the image were determined and individually statistically compared to the healthy mucosal color values. Pixels falling outside two standard deviations were highlighted as abnormal and displayed on the original image to make the physician aware of the potential mucosal abnormality.
Multimodality Image Fusion
Adaptation of the 2-D optical image information to 3-D structures has the advantage of greatly increasing the structural composition of the image scene. The initial step in this 3-D feature extraction is to correct the barrel distortion present in the macro-optical images acquired with the color bronchoscope imaging system. An example of this correction is presented in Fig. 8 . Through the utilization of the pixel location look-up table, this correction occurs in processing times close to that of real-time analysis.
Due to the complexity of extracting the initialization parameters for the SFS algorithm from the virtual bronchoscopy software, this process is performed after image collection. The input to the SFS algorithm in addition to the initialization depth and location, is both the distortion corrected image and the color-analyzed distortion-corrected image, the first of which is required to extract the scene shading information and the second to map the color texture including the highlighted abnormal mucosal colors. The resulting 3-D color image structures are then displayed using an interactive graphical user interface that enables user-defined image rotation, translation, and scaling to enable full exploration of the 3-D image scene ͑see Fig. 9͒ .
In this early stage, we limited our fusion of color and structure information to single macro-optical images. With the inclusion of additional frames we believe that the accuracy of the structural reconstruction through SFS will be greatly refined. This extension to multiframe SFS image reconstruction will result in mucosal surfaces being imaged at a number of angles a number of times. By determining the interframe correspondences, the 3-D surfaces can be combined resulting in the convergence of a potentially more accurate structural solution.
Conclusion
Through the development of a pulmonary mucosal imaging system that utilizes an Olympus trichromatic CCD chip bronchoscopes we were able to perform comparative airway mucosal color analyses. We collected mucosal hue and saturation values for both healthy and diseased pulmonary airways and showed that, as hypothesized, the values can be used to distinguish between the various disease classes. Statistical comparison of airway mucosal color to that in the developed healthy normative database affords real-time evaluation of the patient airway and subsequently is able to draw the attention of the physician to potentially abnormal airway mucosa, signifying a region possibly suited to further analysis via airway forceps biopsy, or newly developed optical biopsy strategies.
The diagnosis and detection of the state of a patient's airways is generally initiated via visualization of the pulmonary airways either by macro-optical techniques such as bronchoscopy or by external imaging techniques such as MDCT. Both techniques provide valuable information concerning the health of the airway mucosa such as mucosal color, which may be an indicator of airway inflammation, or airway tree structure, which may indicate regions of stenosis where the airway branch closes in on itself. To enhance the abilities of these imaging techniques to aid in the determination of airway structure and function it is desired that the image information be adapted and fused to provide a synergistic dataset. We showed that we are able to successfully utilize the two imaging modalities in small regions to combine both airway structure and mucosal color. Further mapping of the relevant amassed 2-D bronchoscopy color information to the 3-D structural information will enable the construction of a complete model of the pulmonary airway tree. The resulting 3-D true-color airway tree will provide crucial information, specifically the location of any abnormal airway color and texture regions, potentially aiding in the classification of the tissue abnormality into possible disease states.
We believe that this research begins to confirm our hypothesis that objective quantification of airway mucosal color changes in conjunction with topographical changes will facilitate the detection, diagnosis, and evaluation of progression of pulmonary airway disease. 
